Show simple item record

dc.contributor.authorDave, R. V.
dc.contributor.authorKim, B.
dc.contributor.authorCourtney, A.
dc.contributor.authorO'Connell, R.
dc.contributor.authorRattay, T.
dc.contributor.authorTaxiarchi, V. P.
dc.contributor.authorKirkham, J. J.
dc.contributor.authorCamacho, E. M.
dc.contributor.authorFairbrother, P.
dc.contributor.authorSharma, N.
dc.contributor.authorCartlidge, C. W. J.
dc.contributor.authorHorgan, K.
dc.contributor.authorMcIntosh, S. A.
dc.contributor.authorLeff, D. R.
dc.contributor.authorVidya, R.
dc.contributor.authorPotter, S.
dc.contributor.authorHolcombe, C.
dc.contributor.authorCopson, E.
dc.contributor.authorColes, C. E.
dc.contributor.authorCutress, R. I.
dc.contributor.authorGandhi, Ashu
dc.contributor.authorKirwan, Cliona C
dc.date.accessioned2021-05-18T08:48:17Z
dc.date.available2021-05-18T08:48:17Z
dc.date.issued2021en
dc.identifier.citationDave RV, Kim B, Courtney A, O’Connell R, Rattay T, et al. Correction: Breast cancer management pathways during the COVID-19 pandemic: outcomes from the UK ‘Alert Level 4’ phase of the B-MaP-C study. Br J Cancer. 2021 Apr 12en
dc.identifier.pmid33846526en
dc.identifier.doi10.1038/s41416-021-01378-xen
dc.identifier.urihttp://hdl.handle.net/10541/624055
dc.description.abstractNoneen
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1038/s41416-021-01378-xen
dc.titleCorrection: Breast cancer management pathways during the COVID-19 pandemic: outcomes from the UK 'Alert Level 4' phase of the B-MaP-C studyen
dc.typeOtheren
dc.contributor.departmentThe Nightingale Breast Cancer Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, M23 9LT, Uen
dc.identifier.journalBritish Journal of Canceren
dc.description.noteen
refterms.dateFOA2021-05-18T14:09:11Z


Files in this item

Thumbnail
Name:
33846526.pdf
Size:
288.4Kb
Format:
PDF
Description:
From UNPAYWALL

This item appears in the following Collection(s)

Show simple item record